Your browser doesn't support javascript.
loading
Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.
Cerdá-Fuertes, Nuria; Stoessel, Marc; Mickeliunas, Gintaras; Pless, Silvan; Cagol, Alessandro; Barakovic, Muhamed; Maceski, Aleksandra Maleska; Álvarez González, Cesar; D' Souza, Marcus; Schaedlin, Sabine; Benkert, Pascal; Calabrese, Pasquale; Gugleta, Konstantin; Derfuss, Tobias; Sprenger, Till; Granziera, Cristina; Naegelin, Yvonne; Kappos, Ludwig; Kuhle, Jens; Papadopoulou, Athina.
Afiliação
  • Cerdá-Fuertes N; Department of Clinical Research, University Hospital of Basel, University of Basel, Basel, Switzerland.
  • Stoessel M; Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Mickeliunas G; Research Center for Clinical Neuroimmunology and Neuroscience, University of Basel, Basel, Switzerland.
  • Pless S; Neurostatus AG, University Hospital of Basel, Basel, Switzerland.
  • Cagol A; Department of Clinical Research, University Hospital of Basel, University of Basel, Basel, Switzerland.
  • Barakovic M; Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Maceski AM; Research Center for Clinical Neuroimmunology and Neuroscience, University of Basel, Basel, Switzerland.
  • Álvarez González C; Psychiatry Clinic, University Hospital of Zürich, Zürich, Switzerland.
  • D' Souza M; Research Center for Clinical Neuroimmunology and Neuroscience, University of Basel, Basel, Switzerland.
  • Schaedlin S; Faculty of Psychology and interdisciplinary Platform Psychology and Psychiatry, Division of Molecular and Cognitive Neuroscience, University of Basel, Basel, Switzerland.
  • Benkert P; Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Calabrese P; Research Center for Clinical Neuroimmunology and Neuroscience, University of Basel, Basel, Switzerland.
  • Gugleta K; Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Derfuss T; Research Center for Clinical Neuroimmunology and Neuroscience, University of Basel, Basel, Switzerland.
  • Sprenger T; Research Center for Clinical Neuroimmunology and Neuroscience, University of Basel, Basel, Switzerland.
  • Granziera C; Neurostatus AG, University Hospital of Basel, Basel, Switzerland.
  • Naegelin Y; Neurostatus AG, University Hospital of Basel, Basel, Switzerland.
  • Kappos L; Department of Clinical Research, University Hospital of Basel, University of Basel, Basel, Switzerland.
  • Kuhle J; Research Center for Clinical Neuroimmunology and Neuroscience, University of Basel, Basel, Switzerland.
  • Papadopoulou A; Department of Clinical Research, University Hospital of Basel, University of Basel, Basel, Switzerland.
Mult Scler ; 29(13): 1540-1550, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37772490
ABSTRACT

BACKGROUND:

Optical coherence tomography (OCT) is a biomarker of neuroaxonal loss in multiple sclerosis (MS).

OBJECTIVE:

The objective was to assess the relative role of OCT, next to magnetic resonance imaging (MRI) and serum markers of disability in MS.

METHODS:

A total of 100 patients and 52 controls underwent OCT to determine peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell-inner plexiform layers (GCIPL). Serum neurofilament light chain (sNfL), total lesion volume (TLV), and brain parenchymal fraction (BPF) were also assessed. The associations of OCT with disability were examined in linear regression models with correction for age, vision, and education.

RESULTS:

In patients, pRNFL was associated with the Symbol Digit Modalities Test (SDMT; p = 0.030). In the multivariate analysis including sNfL and MRI measures, pRNFL (ß = 0.19, p = 0.044) and TLV (ß = -0.24, p = 0.023) were the only markers associated with the SDMT. pRNFL (p < 0.001) and GCIPL (p < 0.001) showed associations with the Expanded Disability Status Scale (EDSS). In the multivariate analysis, GCIPL showed the strongest association with the EDSS (ß = -0.32, p < 0.001) followed by sNfL (ß = 0.18, p = 0.024).

CONCLUSION:

The associations of OCT measures with cognitive and physical disability were independent of serum and brain MRI markers of neuroaxonal loss. OCT can be an important tool for stratification in MS, while longitudinal studies using combinations of biomarkers are warranted.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Idioma: En Ano de publicação: 2023 Tipo de documento: Article